Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol in STEMI patients with preserved LVEF
NCT01155635Phase 4Completed
- Start
- Jul 2010
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of carvedilol in ST elevation myocardial infarction (STEMI) (2 arms). Primary endpoints: All cause mortality at 6 years and Composite of death, myocardial infarction, acute coronary syndrome, heart failure hospitalization at 6 years. Started Jul 2010; status: completed.
02
Drugs
carvedilol
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01155635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01155635.